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Background
Recent evidence in the literature has reported the asso-
ciation between the soluble bioactive form of TNF-like
weak inducer of apoptosis (sTWEAK) to insulin resis-
tance, type 2 DM, chronic kidney disease, and athero-
sclerosis. To date, just a single study has evaluated this
novel inflammatory cytokine in Metabolic Syndrome
(MetS), showing a reduction in the circulating levels of
sTWEAK in elder Caucasian patients (>97% hyperten-
sive) at high cardiovascular risk. Nevertheless, is not
known whether individuals from a mixed population at
the primary care may exhibit or not similar changes.
Objectives
The aims of this study were to investigate the associa-
tion between MetS and biomarkers of chronic inflam-
mation (plasma sTWEAK) and oxidative stress (AOPP,
Nox, FRAP) in postmenopausal women recruited at
community level.
Materials and methods
This cross-sectional analysis enrolled 157 women from a
previous community-based study of 1057 postmenopausal
women covering all basic health units from the municipal-
ity of Santa Maria-RS. Participants answered a question-
naire including the clinical history and co-morbidities and
were submitted to anthropometric evaluation (height,
weight, abdominal circumference), measurement of blood
pressure and blood sample collection. Plasma levels of
sTWEAK were assessed by ELISA. Biochemical analysis
(glucose, LDL, HDL, triglycerides) and oxidative stress
markers (AOPP, Nox and FRAP) were determined in
serum as previously described. The definition of MetS was
based by established criteria of the International Diabetes
Federation (IDF). This study was approved by the local
Ethics Committee. Assimetric data was logN transformed.
The significance level was set at P<0.05.
Results
No differences in age were observed between postmeno-
pausal women of non-MetS(n=42) and MetS (n=115)
groups. The (mean + SD) of age was, respectively, 66.6 +
7 y and 68.6 + 6 y in non-MetS and MetS. The diagnosis
of hypertension was present in 17% of non-MetS and
85% of MetS women. Interestingly, FRAP levels were sig-
nificantly higher in MetS (522.6 + 296 µmol/L) against
non-MetS (411.1 + 221 µmol/L)(p=0.02). sTWEAK in
plasma was reduced in MetS ( 282.9 + 158 pg/mL) versus
non-MetS (338.3 +162 pg/mL) and reach significance
after logN transformation (p=0.027).
Conclusion
Our Results supports for the first time a disruption of
(sTWEAK) and oxidative stress marker (FRAP) in post-
menopausal women with MetS in a mixed population
obtained from a community-based study.
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